Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04347720Completed

Canadian National PDA Treatment Study

Role: collaborator

NCT01852695Not ApplicableUnknown

Family Integrated Care in the NICU

Role: collaborator

NCT02306577Unknown

STRIBILD in Non-Nucleoside Resistant Patients (SINNR STUDY)

Role: collaborator

NCT00840008Phase 4Completed

The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding

Role: collaborator

All 4 trials loaded